HomeProductAntiasthmatic & COPD PreparationsAntiasthmatic & COPD Preparations

COMBIVENT 2.5MG/5MG 2.5ML

COMBIVENT 2.5MG/5MG 2.5ML

Code : COM01

Price: 8 USD

BOEHRINGER;

BOX OF 10'S VIAL

Manufacturer                          
  •       BOEHRINGER INGELHEIM
Present/Packing          Combivent inhalation solution - Combivent (unit-dose vial) 2.5 mL x 10's   
Price                    

Features                     
Delivery



 

Share this product to others

Shopping
guide
Add to cart

 

 COMBIVENT

Manufacturer:

         Boehringer Ingelheim

Contents:

         Ipratropium Br 0.5 mg, salbutamol 2.5 mg

Indications:

         Management of reversible bronchospasm associated w/ obstructive airways diseases in patients who require more than a single bronchodilator.

 

 

 

Contraindications:

 

         Hypertrophic obstructive cardiomyopathy or tachyarrhythmia. Hypersensitivity to atropine/its derivatives.

Special Precautions:

         Patients predisposed to glaucoma, insufficiently controlled DM, recent MI, severe organic heart or vascular disorders, patients w/ underlying severe heart disease, hyperthyroidism, phaeochromocytoma, risk of narrow-angle glaucoma, prostatic hypertrophy or bladder neck obstruction, hypoxia, cystic fibrosis. Patients w/ hepatic or renal insufficiency. Pregnancy & lactation. Not indicated for ped patients.

Dosage:

          Acute attacks: 1 unit dose vial. In severe cases not relieved by 1 unit dose vial, the administration of the 2nd unit dose vial may be required; patients should consult a doctor immediately. Maintenance: 1 unit dose vial tds or qds.

Class:

          Antiasthmatic & COPD Preparations

Presentation/Packing:

          Combivent inhalation solution - Combivent (unit-dose vial) 2.5 mL x 10's

Price:

          Contact us for a good price

Details:

          nhathuoctot.com - 0937146168

Ipratropium Br 0.5 mg, salbutamol 2.5 mg

Acute attacks: 1 unit dose vial. In severe cases not relieved by 1 unit dose vial, the administration of the 2nd unit dose vial may be required; patients should consult a doctor immediately. Maintenance: 1 unit dose vial tds or qds.

Updating

Patients predisposed to glaucoma, insufficiently controlled DM, recent MI, severe organic heart or vascular disorders, patients w/ underlying severe heart disease, hyperthyroidism, phaeochromocytoma, risk of narrow-angle glaucoma, prostatic hypertrophy or bladder neck obstruction, hypoxia, cystic fibrosis. Patients w/ hepatic or renal insufficiency. Pregnancy & lactation. Not indicated for ped patients.

Rating

(based on 0 rating)

We want to know your comment!


Write a review


     
  Rating
  Email *
  Fullname *
  Title *
  Content *
  Confirm code *